公开(公告)号：US20190284135A1

公开(公告)日：2019-09-19

申请号：US16421006

申请日：2019-05-23

Applicant: AbbVie Inc.

Inventor： Dominique Bonafoux ,  Heather Michele Davis ,  Kristine E. Frank ,  Michael M. Friedman ,  J. Martin Herold ,  Michael Z. Hoemann ,  Raymond Huntley ,  Augustine Osuma ,  George Sheppard ,  Gagandeep Kaur Somal ,  Jennifer Van Camp ,  Stacy Anne Van Epps ,  Anil Vasudevan ,  Grier Allan Wallace ,  Lu Wang ,  Lu Wang ,  Zhi Wang ,  Noel S. Wilson ,  Xiangdong Xu

IPC: C07D209/08 ,  C07D487/04 ,  C07D405/14 ,  C07D231/56 ,  C07D403/14 ,  C07D401/14 ,  C07D417/14 ,  C07D471/04 ,  C07D417/12 ,  A61P35/00 ,  C07D513/04 ,  C07D209/14 ,  C07D409/04 ,  C07D409/12 ,  C07D409/14 ,  C07D209/10 ,  C07D209/12 ,  C07D413/04 ,  C07D209/18 ,  C07D401/04 ,  C07D403/04 ,  C07D403/10 ,  C07D405/04 ,  C07D401/12

Abstract: The invention provides compounds of Formula (I) pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.

公开(公告)号：US20210179556A1

公开(公告)日：2021-06-17

申请号：US17173613

申请日：2021-02-11

Applicant: AbbVie Inc.

Inventor： Dominique Bonafoux ,  Heather Michele Davis ,  Kristine E. Frank ,  Michael M. Friedman ,  J. Martin Herold ,  Michael Z. Hoemann ,  Raymond Huntley ,  Augustine Osuma ,  George Sheppard ,  Gagandeep Kaur Somal ,  Jennifer Van Camp ,  Stacy Anne Van Epps ,  Anil Vasudevan ,  Grier Allan Wallace ,  Lu Wang ,  Lu Wang ,  Zhi Wang ,  Noel S. Wilson ,  Xiangdong Xu

IPC: C07D209/08 ,  C07D487/04 ,  C07D417/12 ,  C07D471/04 ,  C07D417/14 ,  C07D401/14 ,  C07D403/14 ,  C07D231/56 ,  C07D401/12 ,  A61P35/00 ,  C07D513/04 ,  C07D209/10 ,  C07D209/12 ,  C07D209/14 ,  C07D209/18 ,  C07D401/04 ,  C07D403/04 ,  C07D403/10 ,  C07D405/04 ,  C07D405/14 ,  C07D409/04 ,  C07D409/12 ,  C07D409/14 ,  C07D413/04

Abstract: The invention provides compounds of Formula (I) pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.